These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 143305)

  • 1. [Metabolic activation by adrenal tissue in rats of a liver carcinogen: safrole].
    Doumas J; Maume BF
    C R Seances Soc Biol Fil; 1977; 171(1):108-14. PubMed ID: 143305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study in cultured rat liver cells of the metabolism of different analogues and metabolites of a natural hepatocarcinogen: safrol].
    Janiaud P; Delaforge M; Levi P; Maume BF; Padieu P
    C R Seances Soc Biol Fil; 1976; 170(5):1035-41. PubMed ID: 139975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of isosafrole and dihydrosafrole in the rat.
    Klungsøyr J; Scheline RR
    Biomed Mass Spectrom; 1982 Aug; 9(8):323-9. PubMed ID: 7126764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1'-sulfoöxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'-hydroxysafrole in mouse liver.
    Boberg EW; Miller EC; Miller JA; Poland A; Liem A
    Cancer Res; 1983 Nov; 43(11):5163-73. PubMed ID: 6577945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The occurrence of glucuroconjugated metabolites of safrole in the urine of treated rats].
    Levi P; Janiaud P; Delaforge M; Morizot JP; Maume BF; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(5):1034-40. PubMed ID: 146545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
    Fennell TR; Miller JA; Miller EC
    Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues.
    Wiseman RW; Fennell TR; Miller JA; Miller EC
    Cancer Res; 1985 Jul; 45(7):3096-105. PubMed ID: 4005847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens.
    Wislocki PG; Borchert P; Miller JA; Miller EC
    Cancer Res; 1976 May; 36(5):1686-95. PubMed ID: 5188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole.
    Miller EC; Swanson AB; Phillips DH; Fletcher TL; Liem A; Miller JA
    Cancer Res; 1983 Mar; 43(3):1124-34. PubMed ID: 6825084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of safrole in the rat.
    Klungsøyr J; Scheline RR
    Acta Pharmacol Toxicol (Copenh); 1983 Mar; 52(3):211-6. PubMed ID: 6846029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites.
    Wislocki PG; Miller EC; Miller JA; McCoy EC; Rosenkranz HS
    Cancer Res; 1977 Jun; 37(6):1883-91. PubMed ID: 192464
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic activation of a natural promutagen, eugenol, by replicative cultures of adult rat liver epithelial cells].
    Delaforge M; Janiaud P; Dorange JL; Morizot JP; Padieu P
    C R Seances Soc Biol Fil; 1977; 171(1):100-7. PubMed ID: 143304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Properties of the safrole metabolite-cytochrome P-450 complex.
    Elcombe CR; Bridges JW; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R72. PubMed ID: 1143487
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption, metabolism and excretion of safrole in the rat and man.
    Benedetti MS; Malnoë A; Broillet AL
    Toxicology; 1977 Feb; 7(1):69-83. PubMed ID: 14422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding of safrole to cytochrome P-450.
    Delaforge M; Ioannides C; Parke DV
    Arch Toxicol Suppl; 1980; 4():45-8. PubMed ID: 6933961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
    Murray M; Reidy GF
    Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic sulfonation and side-chain oxidation of 3'-hydroxyisosafrole in the mouse and its inactivity as a hepatocarcinogen relative to 1'-hydroxysafrole.
    Boberg EW; Miller EC; Miller JA
    Chem Biol Interact; 1986; 59(1):73-97. PubMed ID: 3757147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of safrole and 2',3'-epoxysafrole in the rat and guinea pig.
    Stillwell W; Carman JK; Bell L; Horning MG
    Drug Metab Dispos; 1974; 2(6):489-98. PubMed ID: 4155673
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulfuric acid esters as ultimate electrophilic and carcinogenic metabolites of some alkenylbenzenes and aromatic amines in mouse liver.
    Miller EC; Miller JA; Boberg EW; Delclos KB; Lai CC; Fennell TR; Wiseman RW; Liem A
    Carcinog Compr Surv; 1985; 10():93-107. PubMed ID: 3904999
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between the metabolism and toxicity of benzodioxole compounds.
    Bridges JW; Fennell TR
    Adv Exp Med Biol; 1981; 136 Pt B():881-93. PubMed ID: 7344519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.